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Abstract
Introduction: Renal papillary pits are commonly encountered during ureteroscopy. The mechanism by which
such pits arise is unclear. One hypothesis is that pits represent sites where stones overgrowing Randall’s plaque
(RP) were dislodged. We sought to examine this theory by using digital ureteroscopy and stone lCT.
Materials and Methods: Patients undergoing endoscopic stone removal had procedures recorded and stones
analyzed by using lCT. Stones with evidence of Randall’s plaque anchors (RPAs) were identified in a blinded
fashion. Surgical videos were reviewed independently by two urologists.
Results: Twenty-eight patients had lCT-confirmed stones with RPA. Among them, 93% were recurrent stone
formers and 75% had had prior stone procedures. Metabolic abnormalities were present in 87%, with 79%
classified as idiopathic calcium oxalate stone formers. A mean of 7.6 stones with RPA were identified per
procedure. In each case, papillary pits were visualized before any stone manipulation and in several cases the
active dislodgement of an attached stone led to immediate identification of an underlying pit. Such stones
routinely demonstrated an RPA on lCT. The average depth of RPA was 302– 172lm, consistent with the
corresponding shallow pits visualized on the papillary surface.
Conclusions: Stones overgrowing RP are capable of pulling away a piece of papilla when dislodged, resulting
in a visible papillary pit. This process manifests as an RPA on the undersurface of the stone and a papillary pit
on the corresponding area of attachment. Identification of pits may help identify patients who form stones
primarily by the RP mechanism.
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Introduction
Papillary pathology is increasingly recognized as apotential source of information in studying kidney stone
pathogenesis. The renal papillae of stone formers differ from
non-stone formers and have unique appearances depending
on underlying pathophysiologies that are responsible for
stone formation.1,2 Mechanisms by which changes in the
papilla occur are poorly understood, though their presence
has been hypothesized to have clinical relevance in classi-
fying patients more precisely for the purposes of research and
clinical care.
Recently, two endoscopic papillary classification systems
have been described to help standardize the description of
papillary abnormalities.3,4 One feature common to each is rec-
ognition of papillary pits (surface erosion) whereby the normally
smooth urothelial surface of the papilla is disrupted. The pres-
ence of papillary pits has been reported by Traxer and colleagues
as the most common abnormality identified after Randall’s
plaque (RP).4 Recent investigation of papillary classification
among patients undergoing ureteroscopy demonstrated a strong
association between RP and papillary pitting and hypothesized
that pitting occurred as a result of stone overgrowth on RP with
subsequent tearing off of a piece of superficial epithelium with
the stone when dislodgement occurred.5 However, concrete
mechanistic evidence for this process is lacking.
Our research team has recently described the ability of
using lCT to reliably identify RP attachments to stones that
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we term Randall’s plaque anchors (RPA).6,7 Patients with
such stones represent an ideal cohort to test the hypothesis
that papillary pits occur secondary to RP stone dislodge-
ment as the presence of RPA on the stone should presum-
ably correspond to papillary pits if this process does, in fact,
occur. Confirmation of this mechanism would enhance our
understanding of one feature of abnormal papillary pathol-
ogy commonly observed during renal endoscopy for stone
treatment.
Methods
Patients were enrolled as part of an ongoing IRB-approved
study (IRB No. 1010002261) to investigate mechanisms of
stone pathogenesis using endoscopic surgical observations
and metabolic testing. Our research methodology has been
previously described.6 Attempts are made to remove all
stones intact. The endoscopic video is recorded and saved in
high definition.
Stones were examined individually, first grossly and then
with lCT by an expert in this area ( J.C.W.). lCT is non-
destructive and allows identification of mineral subtypes and
microstructure.6–8 Mineral composition was confirmed in
each case by using infrared spectroscopy. Reports from all
stone lCTs were generated and recorded in a manner blinded
to surgical observations and patient data.
Surgical videos from the corresponding procedures were
reviewed independently by two urologists specializing in
endourology and stone disease to determine whether any
papillae showed evidence of pits. The identification of pits
was based on previously published descriptions of this pro-
cess whereby a superficial ulceration is visualized on the
normally smooth and intact papillary surface.3,4
Results of corresponding serum and urine metabolic
testing performed while off preventive pharmacologic
agents were reviewed. Patients were categorized based on
stone mineral composition and metabolic pathophysiology
as previously described in prior publications.1,9,10 De-
scriptive statistics were performed by using JMP 12.2 (SAS,
Cary, NC).
Results
lCT stone reports were available for 166 patients under-
going stone removal procedures from 2010 to 2016. Twenty-
eight of these patients (17%) had at least one stone with
evidence of an RPA and are the subject of this study (Fig. 1).
RPA were identified on high-resolution (generally 3 lm
voxel size) lCT by the following criteria7: The stone pos-
sessed a region of apatite at its surface that was distinct from
the mineral making up the stone; the apatite did not have a
layered appearance (common to apatite growing in the ur-
ine)11 but instead showed a moderate level of X-ray attenu-
ation that diminished in the edges of the apatite region away
from the stone. Most often, these apatite regions contained
empty cylindrical spaces that twisted through the mineral,
typically with a diameter of 20 to 30 lm, consistent with
these being the remaining lumens of tubules and vessels that
ran through the mineralized region. Finally, not uncom-
monly, a profile at the edge of the apatite away from the stone
was seen that appeared to be a tubule with a calcified wall,
consistent with what has been proposed to be the earliest
FIG. 1. lCT appearance of stones with morphological
evidence of RPAs. Both stones here were collected from the
same patient. (A) One of seven attached stones was removed
during the procedure, all of which showed RPAs. Upper left,
photo of stone after removal, on mm grid paper. Background
is 3D surface rendering of lCT image stack. Upper right is
portion of lCT image slice showing lumen of tubule cap-
tured in cross-section. Lower right shows ureteroscopic
view of papilla before stone was removed; inset shows stone
and eroded regions colorized. (B) Spontaneously passed
stone collected by patient before procedure. RPA is hidden
in photo, upper left, but clearly seen in surface rendering,
background. Magnified view of RPA shows evidence of
lumens (inset), with appearance somewhat obscured, likely
because of mineral deposited on the RPA from the urine
while the stone was being passed. 3D, three-dimensional;
RPAs, Randall’s plaque anchors.
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stage of the formation of RP, namely the deposition of min-
eral into the basement membrane of a loop of Henle.10
Demographics of these RP stone formers are described
in Table 1. The majority were classified as idiopathic
calcium oxalate stone formers. Complete metabolic as-
sessment was accomplished by 22/28 patients (78.5%), a
majority of whom (86.4%) were found to have at least one
metabolic risk factor for stone formation. The most com-
monly observed abnormality was hypercalciuria (59.0%),
followed by hypocitraturia (54.5%) and hyperoxaluria
(36.3%) (Table 1).
A total of 213 stones with RPA (out of 524 total stones)
were identified from the 28 patients in this cohort (mean 7.6
RPA stones/patient procedure [range 1–40]). The mineral
composition of the RPA itself was identified as apatite in
all cases. The majority of RPA (86%) showed evidence of
luminal spaces, consistent with tubules or vessels trapped in
the plaque (Fig. 1). Mean dimensions of the RPA were
340– 224lm wide (measured along the stone-plaque inter-
face) and 302 – 172 lm deep (measured from the stone-
plaque interface to the furthest extension of plaque). Analysis
of the overgrowing stones revealed the majority to be pure
calcium oxalate (62%), with the remainder showing a mixed
composition of calcium oxalate and apatite. Overall, the
maximum dimension of the combined RPA and overgrowing
stone was 2.0 – 1.2 mm.
On review of the endoscopic surgical procedures, all pa-
tients demonstrated evidence of attached stones to at least one
papilla. Papillary pits were identified on at least one papilla in
all patients as well. Occasionally, we had the opportunity to
observe a papillary pit immediately on stone removal (Fig. 2)
though this was not possible in all cases owing to stone lo-
cation relative to the papilla and the ureteroscope. Notably,
pits were identified before any direct stone manipulation in
seven patients with no history of prior stone procedures. In
each case, at least one papillary pit was able to be observed
immediately on entry to the kidney before any stone ma-
nipulation, suggesting that the visualized pits may have
formed from spontaneous, rather than iatrogenic, dislodge-
ment of a stone. This is supported by the stone analyses in
Figure 1, whereby a patient had brought in several sponta-
neously passed stones before undergoing planned uretero-
scopy. RPA were visualized on the spontaneously passed and
mechanically removed stones alike.
We also had the opportunity to examine the papillae of one
patient in two different bilateral procedures that occurred 330
days apart. A total of 32 papillae from the 2 kidneys were
able to be matched between the videos of the 2 procedures,
and the papillary appearances were nearly identical in every
case. Figure 3 shows representative papillae from this case
whereby the gross appearance of the identified pits was stable
over nearly 1 year, suggesting that pitting is a relatively stable
Table 1. Demographics of Patients with Randall’s
Plaque Anchors on Stones
Variable N (range)
Stone phenotype
Idiopathic calcium oxalate 22
Idiopathic hydroxyapatite 3
Brushite 1
Enteric hyperoxaluria 1
Primary hyperparathyroid 1
Procedure
Ureteroscopy 24
Percutaneous nephrolithotomy 4
Age at surgery 41.6 (9–72)
Female (%) 43
BMI (kg/m2) 28.8 (17.5–47.4)
Prior stone history, % 92.80
Prior stone procedure, % 75
Number of prior stone procedures 2.77 (0–19)
Family history, % 43
Serum calcium (mg/dL) 9.46 (8.7–10.4)
Urine volume (L) 1.96 (1.2–3.3)
Urine sodium (mg/day) 171.5 (86–269.5)
Urine calcium (mg/day) 227.1 (45.5–420)
Urine oxalate (mg/day) 39.9 (24.5–95)
Urine citrate (mg/day) 560.2 (19–1484.5)
Urine pH 6.16 (5.3–6.9)
Urine supersaturation calcium oxalate 7.48 (2.3–12.6)
Urine supersaturation
calcium phosphate
1.49 (0.1–2.3)
Urine Ca/kg 2.74 (0.6–4.8)
Urine Ca/Cr 147.0 (46.5–294.9)
Urine Cr/kg 19.4 (10.1–26)
BMI= body mass index.
FIG. 2. Demonstration of
pit creation after stone dis-
lodgement. (A) Papilla with
large amount of RP desig-
nated by arrowheads. There
is an attached stone overlying
the papilla (arrow). (B) Stone
is mechanically dislodged
from papillary tip with stone
basket, revealing underlying
surface pit in the papilla.
RP=Randall’s plaque.
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phenomenon in this type of patient and not a transient process
that is only visible shortly on dislodgement of a stone.
Discussion
Digital ureteroscopes have provided an unprecedented
ability to inspect the renal papillae during ureteroscopic stone
treatment, leading to the realization that renal papillary ab-
normalities are very common in patients who form stones.6
One of the most common abnormalities encountered, papil-
lary pits, are believed, in some instances, to occur after an
adherent stone is dislodged but there is scant evidence sup-
porting this hypothesis. Herein, we describe one such
mechanism whereby a piece of the papilla is lost when the
stone is shed and can be seen microscopically still adherent to
the stone in the form of an RPA. Further, in patients whose
stones feature RPA, papillary pits are present on at least one
papilla in 100% of cases.
This process has been previously alluded to. In 1973, Elliot
and colleagues analyzed 150 spontaneously passed ureteral
stones with low power magnification and identified depres-
sions in nearly half. In many, a small, cream-colored focus
was seen in the depression, which, when analyzed, was found
to nearly always be apatite, consistent with RP.12 In 1975,
Prien hypothesized that this lesion originated as papillary
plaque, sloughed from the papilla during stone passage. In
some instances, he even described bits of papillary tissue still
adherent to the stone.13 In 1985, through scanning electron
microscopy of spontaneously passed stones, Cifuentes De-
latte and colleagues later verified that luminal spaces in the
RP nucleus were consistent with renal tubules, blood, and
lymph capillaries running toward the surface of the papilla.14
We, too, have previously recognized that a high percentage of
stones removed from kidneys of idiopathic calcium oxalate
stone formers show morphologic evidence of having origi-
nated on RP with papillary depressions and apatite nuclei
underlying calcium oxalate overgrowths.15
Our identification of 218 unique stones exhibiting RPA is,
by far, the largest ever reported. We are also the first to report
the corresponding papillary appearance from such patients.
Our findings of papillary pits in 100% of such patients pro-
vide a plausible explanation as to one way in which papillary
pits may form and they are further strengthened by the di-
rect observation of papillary pits identified immediately on
dislodgement of attached stones. Papillary pits are likely
capable of forming spontaneously and not just via iatro-
genic processes. As mentioned, RPA are known to occur on
spontaneously passed stones. Moreover, 7 out of 7 patients
undergoing their initial stone treatment in this series dem-
onstrated evidence of pitting before stone extraction. No-
tably, all but one of these patients reported a prior history of
spontaneous stone passage, making it strongly suggestive that
pits seen at the time of endoscopy may have formed at the
time of prior spontaneous stone dislodgement. We are also
confident that pits are not just a transient process as evidenced
by the re-demonstration of nearly identical papillary ap-
pearances over an 11-month period in one of the patients
included in this study.
Recognition that pits can occur in response to RP stone
dislodgement is useful as continued efforts are being made to
improve the way in which patients with nephrolithiasis are
classified. Current classification mechanisms are insufficient
and lack insight into the stone formation mechanism. For
example, stone mineral analysis varies widely between labs16
and results of 24-hour urine testing have been found to
be inadequate in nearly 50% of cases when performed in non-
research settings.17 Recently, Letavernier and colleagues
suggested that the mechanism of stone formation be con-
sidered when classifying stone formers. RP formation, in
particular, has been suggested to have clinical relevance as
patients who form stones this way have been found to have
earlier onset of stone disease and high likelihoods of meta-
bolic abnormalities.18
Two endoscopic papillary grading systems have been re-
cently introduced to serve as an adjunct to established
mechanisms to classify stone formers.3,4 Each of these sys-
tems is based predominantly on the presence of papillary
abnormalities; however, the corresponding meaning and
implications of the abnormalities have yet to be fully ap-
preciated. Herein, we provide a previously undescribed cor-
relation between papillary abnormality and stone formation
that might help advance the field.
The clinical and research implications of identifying
this mechanism for papillary pitting are significant. First,
FIG. 3. Stability of papillary pitting. These images show
the same papillae from ureteroscopic procedures that took
place almost 11 months apart. These papillae are quite rep-
resentative of 32 such papillae that were matched between the
videos of the 2 procedures. Note that the RP regions (white)
of the papilla in the foreground surround a region of pitting
that is apparently unchanged between 2015 and 2016.
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papillary pits are a very common endoscopic finding. They
are a central component of both endoscopic papillary clas-
sification systems. In the classification system described by
Almeras and coworkers, pitting was the most commonly
observed abnormality besides RP itself.4 Further, application
of the system described by Borofsky and coworkers3 found a
strong correlation between pitting and RP.5 We are now
well poised to study the clinical relevance of this finding. For
example, might papillary pits be useful as a surrogate marker
of stone activity? Data from this cohort would suggest
this to be the case as the vast majority of patients with pits
were recurrent stone formers (93%). Application of this
concept might be useful in combating known underutiliza-
tion of 24-hour urine testing by urologists by helping
identify patients with the highest probability of having the
most meaningful abnormalities.19 Further, the identification
of papillary pits opens numerous opportunities for research.
For example, it remains unclear as to whether these pits are
associated with alterations in renal physiology. If so, per-
haps this process may explain why patients with recurrent
calcium oxalate stones occasionally convert to forming
calcium phosphate stones.20 Alternatively, it remains un-
clear as to whether this apparent injury to the papilla has
any corresponding impact on renal function, suggested to
occur in association with repeated stone events.21 Finally,
we do not know whether RP is able to reform at all once
dislodged. If not, perhaps the superficial shedding of the RP
might explain why the incidence of stone disease declines
with age.22
Our findings must be interpreted in the context of several
limitations. For one, the concept of papillary pitting is rela-
tively new and has only recently gained appreciation. An
alternative papillary pathology with the potential to look
similar to a pit is a widely dilated Bellini duct. Dilated Bellini
ducts are found commonly in the papillae of stone formers
with high degrees of tubular plugging by crystals such as
occur in cystine, brushite, and calcium phosphate stone dis-
ease. Classically, dilated Bellini ducts have a different ap-
pearance from pits and can be distinguished by a deep rather
than superficial extension into the papilla. Further, dilated
ducts classically have discrete edges whereas pits tend to
have more ragged edges, frequently with adjacent RP. We
acknowledge that in certain disease states pits and dilated
ducts may coexist and we are hopeful to formally assess this
as our experience with endoscopic papillary assessment
grows. An additional limitation is that we are unable to de-
finitively match each RP stone to a corresponding pit. In
several instances, however, a papillary pit was able to be
appreciated immediately on dislodgement of an attached
stone (Fig. 2). In many cases, we presume that pits formed at
previous time points. Another limitation is that the patients
included in this study were identified retrospectively on the
basis of stone lCT, making it possible that other mechanisms
may also lead to papillary pits. Finally, our study did not have
a control group. Given our hypothesis that pits form after
stone dislodgement, we would not anticipate seeing any in the
papilla of non-stone formers and plan to formally assess this
in future research efforts.
Our study has several strengths as well. Most notably, the
lCT data presented is the largest in the published literature.
Further, the inclusion of seven patients undergoing their first
stone treatment, each of whom demonstrated pitting, suggests
that this is not merely a surgical induced process resulting
from direct stone removal.
Conclusions
RP is able to be reliably identified by using lCT. Papillary
pits were identifiable on at least one papilla from such pa-
tients in 100% of cases. Increasing awareness of this common
finding and elucidation of the papillary findings associated
with it may allow greater precision in accurately classifying
stone formers not only by the type of mineral that their stones
are composed of but also by the underlying formation
mechanism itself. Further work is needed to understand the
implications of such findings, in particular how the presence
and relative degree of papillary pits may be used to classify
and risk stratify stone formers.
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